Our findings revealed markedly elevated TNF-α levels in CR-TRS patients with MetS compared to those without MetS, suggesting TNF-α‘s potential utility as a predictive marker for distinguishing between CR-TRS patients with and without MetS. The gene discussed is TNF; the disease is metabolic syndrome.